Loading
Chung-Hsin Wang

Chung-Hsin Wang

General Manager, Trust Bio-sonics Inc.
CH Wang, the founder, and technical innovator of Trust Bio-sonics Inc. (TBS). Prior to establishing the company, Dr. Wang and the research team in National Tsing Hua University conducted extensive research in the field of ultrasound imaging and ultrasound-mediated drug delivery technologies. He contributed to the team's development of ultrasound microbubbles and phase-change droplets for drug delivery, aiming to overcome challenges in treating difficult-to-cure cancer diseases. After establishing Trust Bio-sonics, Dr. Wang is primarily responsible for the development of the company's core technology, the roadmap of product development, and subsequent commercialization efforts. TBS' most leading candidate, TBS-002 (i.e. NH002) microbubbles, has successfully entered the Phase III clinical trial stage in both the U.S. and Taiwan. In addition to TBS-002’s original applications in cardiovascular disease and cancer diagnosis, TBS' team has also dedicated significant research efforts over the past five years to build a next-generation drug delivery platform around this microbubble product.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS